Esra Nalbat

E-mail

esra@metu.edu.tr

Department

ORCID

0000-0002-4051-9793

Scopus Author ID

57204015514

Web of Science Researcher ID

AAB-9228-2020

Unveiling Molecular Biomarkers of MASLD Fibrosis: A Transcriptomic and Pathway Enrichment Analysis Nalbat, Esra; Kahraman, Deniz Cansen (2025-02-15)
Prognostic and therapeutic insights into LTBP1 in Hepatocellular Carcinoma: pathway enrichment, immune profiling, and drug repurposing Nalbat, Esra; Gülhan, Rabia Useyma (2025-02-15)
Deciphering Transcriptional Landscapes of Mild and Advanced MASLD Fibrosis: Insights into Differential Gene Expression, Pathway Enrichment, and Drug Repurposing Opportunities Nalbat, Esra; Kahraman, Deniz Cansen (2024-12-20)
In Silico Analysis of Latent Transforming Growth Factor β Binding Protein Family Expression Patterns and Prognostic Value in Hepatocellular Carcinoma Gülhan, Rabia Useyma; Nalbat, Esra (2024-12-18)
CCL2 as a Key Mediator of Neural Invasion in Tumor Progression: An In Silico Study Yıldırım, Barış; Nalbat, Esra (2024-12-18)
Vicinal Diaryl-Substituted Compounds: Promising Therapeutics for Breast Cancer Nalbat, Esra; GÜNTEKİN ERGÜN, SEZEN; TURANLI, SÜMEYYE; LENGERLİ, DENİZ; ÇALIŞKAN, BURCU; BANOĞLU, ERDEN; ATALAY, RENGÜL (2024-06-17)
Hepatocellular Carcinoma: Evaluation of Vicinal Diaryl Isoxazole and Pyrazole Derivatives with Implications for Oxidative Stress and Senescence-mediated Anti-tumor Mechanisms Nalbat, Esra; AKHAN GÜZELCAN, ECE; TURANLI, SÜMEYYE; LENGERLİ, DENİZ; ÇALIŞKAN, BURCU; BANOĞLU, ERDEN; ATALAY, RENGÜL (2024-02-24)
Exploring Cytotoxic Bioactivities of Newly Identified Compounds against Hepatocellular Carcinoma Nalbat, Esra; AKHAN GÜZELCAN, ECE; TURANLI, SÜMEYYE; ÇALIŞKAN, BURCU; BANOĞLU, ERDEN; ATALAY, RENGÜL (2024-02-17)
Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with in Vitro Growth Inhibitory and in Vivo Antitumor Activity Turanll, Sümeyye; Nalbat, Esra; LENGERLİ, DENİZ; İBİŞ, KÜBRA; Güntekin Ergün, Sezen; Akhan Güzelcan, Ece; Muyan, Mesut; Cetin-Atalay, Rengul; Çallşkan, Burcu; BANOĞLU, ERDEN (2022-10-18) The vicinal diaryl heterocyclic framework has been widely used for the development of compounds with significant bioactivities. In this study, a series of diaryl heterocycles were designed and synthesized based on an in-ho...
Network-based in silico modeling for drug repurposing and in vitro validation in hepatocellular carcinoma Nalbat, Esra; Tunçbağ, Nurcan; Cetin-Atalay, Rengul (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10) Hepatocellular carcinoma (HCC) is the sixth most commonly diagnosed cancer and a leading cause of death worldwide. The hyperactivated cell survival signaling pathways cause resistance to conventional chemotherapeutics so t...

Citation Formats